Small-cell carcinoma of the urinary bladder

Diagnosis and management

Chong Xian Pan, Hongyong Zhang, Primo N. Lara, Liang Cheng

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Small-cell carcinoma of the urinary bladder (SCCUB) accounts for less than 1% of all cancers arising in the urinary bladder. Current diagnosis and management of SCCUB are often patterned after small-cell lung cancer (SCLC). However, SCCUB therapy is different from that for SCLC. For example, many patients with SCCUB undergo local resection, which is rarely performed in SCLC. As in SCLC, platinum-etoposide combination chemotherapy is employed as the main systemic treatment option for SCCUB. Chemotherapy is usually combined with other therapeutic modalities, especially in patients whose disease is limited to the locoregional area. Owing to the rarity of this malignancy, no prospective study has been performed that establishes the efficacy and duration of chemotherapy or the relative efficacy of platinum-etoposide versus other chemotherapeutic regimens. This article provides a comprehensive review of the current status of SCCUB diagnosis and management, as well as some unique insights into this rare tumor.

Original languageEnglish
Pages (from-to)1707-1713
Number of pages7
JournalExpert Review of Anticancer Therapy
Volume6
Issue number12
DOIs
StatePublished - Dec 2006

Fingerprint

Small Cell Carcinoma
Urinary Bladder
Small Cell Lung Carcinoma
Etoposide
Platinum
Drug Therapy
Neoplasms
Combination Drug Therapy
Therapeutics
Prospective Studies

Keywords

  • Chemotherapy
  • Radiation therapy
  • Small cell carcinoma of the urinary bladder
  • Small cell lung cancer
  • Targeted therapy

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Small-cell carcinoma of the urinary bladder : Diagnosis and management. / Pan, Chong Xian; Zhang, Hongyong; Lara, Primo N.; Cheng, Liang.

In: Expert Review of Anticancer Therapy, Vol. 6, No. 12, 12.2006, p. 1707-1713.

Research output: Contribution to journalArticle

Pan, Chong Xian ; Zhang, Hongyong ; Lara, Primo N. ; Cheng, Liang. / Small-cell carcinoma of the urinary bladder : Diagnosis and management. In: Expert Review of Anticancer Therapy. 2006 ; Vol. 6, No. 12. pp. 1707-1713.
@article{09c98324d9684551bb57df0f503b6c38,
title = "Small-cell carcinoma of the urinary bladder: Diagnosis and management",
abstract = "Small-cell carcinoma of the urinary bladder (SCCUB) accounts for less than 1{\%} of all cancers arising in the urinary bladder. Current diagnosis and management of SCCUB are often patterned after small-cell lung cancer (SCLC). However, SCCUB therapy is different from that for SCLC. For example, many patients with SCCUB undergo local resection, which is rarely performed in SCLC. As in SCLC, platinum-etoposide combination chemotherapy is employed as the main systemic treatment option for SCCUB. Chemotherapy is usually combined with other therapeutic modalities, especially in patients whose disease is limited to the locoregional area. Owing to the rarity of this malignancy, no prospective study has been performed that establishes the efficacy and duration of chemotherapy or the relative efficacy of platinum-etoposide versus other chemotherapeutic regimens. This article provides a comprehensive review of the current status of SCCUB diagnosis and management, as well as some unique insights into this rare tumor.",
keywords = "Chemotherapy, Radiation therapy, Small cell carcinoma of the urinary bladder, Small cell lung cancer, Targeted therapy",
author = "Pan, {Chong Xian} and Hongyong Zhang and Lara, {Primo N.} and Liang Cheng",
year = "2006",
month = "12",
doi = "10.1586/14737140.6.12.1707",
language = "English",
volume = "6",
pages = "1707--1713",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Small-cell carcinoma of the urinary bladder

T2 - Diagnosis and management

AU - Pan, Chong Xian

AU - Zhang, Hongyong

AU - Lara, Primo N.

AU - Cheng, Liang

PY - 2006/12

Y1 - 2006/12

N2 - Small-cell carcinoma of the urinary bladder (SCCUB) accounts for less than 1% of all cancers arising in the urinary bladder. Current diagnosis and management of SCCUB are often patterned after small-cell lung cancer (SCLC). However, SCCUB therapy is different from that for SCLC. For example, many patients with SCCUB undergo local resection, which is rarely performed in SCLC. As in SCLC, platinum-etoposide combination chemotherapy is employed as the main systemic treatment option for SCCUB. Chemotherapy is usually combined with other therapeutic modalities, especially in patients whose disease is limited to the locoregional area. Owing to the rarity of this malignancy, no prospective study has been performed that establishes the efficacy and duration of chemotherapy or the relative efficacy of platinum-etoposide versus other chemotherapeutic regimens. This article provides a comprehensive review of the current status of SCCUB diagnosis and management, as well as some unique insights into this rare tumor.

AB - Small-cell carcinoma of the urinary bladder (SCCUB) accounts for less than 1% of all cancers arising in the urinary bladder. Current diagnosis and management of SCCUB are often patterned after small-cell lung cancer (SCLC). However, SCCUB therapy is different from that for SCLC. For example, many patients with SCCUB undergo local resection, which is rarely performed in SCLC. As in SCLC, platinum-etoposide combination chemotherapy is employed as the main systemic treatment option for SCCUB. Chemotherapy is usually combined with other therapeutic modalities, especially in patients whose disease is limited to the locoregional area. Owing to the rarity of this malignancy, no prospective study has been performed that establishes the efficacy and duration of chemotherapy or the relative efficacy of platinum-etoposide versus other chemotherapeutic regimens. This article provides a comprehensive review of the current status of SCCUB diagnosis and management, as well as some unique insights into this rare tumor.

KW - Chemotherapy

KW - Radiation therapy

KW - Small cell carcinoma of the urinary bladder

KW - Small cell lung cancer

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=33846068222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846068222&partnerID=8YFLogxK

U2 - 10.1586/14737140.6.12.1707

DO - 10.1586/14737140.6.12.1707

M3 - Article

VL - 6

SP - 1707

EP - 1713

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 12

ER -